Patents by Inventor Matthew Pecukonis

Matthew Pecukonis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8729242
    Abstract: Methods for reducing the T-cell mitogenicity of lectin compositions are provided. In one aspect this is achieved by chemically modifying mitogenic lectin compositions under optimized conditions. Additionally or alternatively, the reduction in T-cell mitogenicity is achieved by removing unmodified subunits chemically modified mixtures. Modified lectin compositions with reduced T-cell mitogenicity are also provided as are uses of the inventive compositions.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: May 20, 2014
    Assignee: Smartcells, Inc.
    Inventors: Thomas M. Lancaster, Wenyi Cai, Ryan Faucette, Matthew Pecukonis, Todd C. Zion
  • Publication number: 20100130726
    Abstract: Methods for reducing the T-cell mitogenicity of lectin compositions are provided. In one aspect this is achieved by chemically modifying mitogenic lectin compositions under optimized conditions. Additionally or alternatively, the reduction in T-cell mitogenicity is achieved by removing unmodified subunits chemically modified mixtures. Modified lectin compositions with reduced T-cell mitogenicity are also provided as are uses of the inventive compositions.
    Type: Application
    Filed: January 27, 2010
    Publication date: May 27, 2010
    Applicant: SMARTCELLS, INC.
    Inventors: Thomas M. LANCASTER, Wenyi CAI, Ryan FAUCETTE, Matthew PECUKONIS, Todd C. ZION
  • Patent number: 7687608
    Abstract: Methods for reducing the T-cell mitogenicity of lectin compositions are provided. In one aspect this is achieved by chemically modifying mitogenic lectin compositions under optimized conditions. Additionally or alternatively, the reduction in T-cell mitogenicity is achieved by removing unmodified subunits chemically modified mixtures. Modified lectin compositions with reduced T-cell mitogenicity are also provided as are uses of the inventive compositions.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: March 30, 2010
    Assignee: SmartCells, Inc.
    Inventors: Thomas M. Lancaster, Wenyi Cai, Ryan Faucette, Matthew Pecukonis, Todd C. Zion
  • Publication number: 20070110811
    Abstract: Methods for reducing the T-cell mitogenicity of lectin compositions are provided. In one aspect this is achieved by chemically modifying mitogenic lectin compositions under optimized conditions. Additionally or alternatively, the reduction in T-cell mitogenicity is achieved by removing unmodified subunits chemically modified mixtures. Modified lectin compositions with reduced T-cell mitogenicity are also provided as are uses of the inventive compositions.
    Type: Application
    Filed: October 19, 2006
    Publication date: May 17, 2007
    Inventors: Thomas Lancaster, Wenyi Cai, Ryan Faucette, Matthew Pecukonis, Todd Zion